FTSE 100 preview: This is Money Drugmaker Shire says a US district court upholds the FDA's grant of 5-year market exclusivity to Vyvanse. GlaxoSmithKline announces a recall of Poligrip in ...

The rise of generic medicines over the past decade or so has fundamentally changed the outlook for the pharmaceutical industry, which suddenly finds itself spending more and more money on research for ever diminishing returns. Courtesy of Pharmboy Hello all! Not a bad month since our first plays in the Pharma and Biotech space. Phil summed up last week the positions and the nice profits on our picks, and I think it is time for a few more companies to focus on for our portfolios (e.g., 100K) , after all, it’s about tilling the soil and making some money on our Pharm …. First, the healthcare debate is going to rage on after the holiday weekend, and I am expecting this sector to take some lumps with our good ri